Aimmune Therapeutics
ID: 5312925Aimmune Therapeutics is a food allergy therapies founded in 2011 by Bryan Walser.
2
Funding Rounds
$97.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** Wa**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Aimmune Therapeutics has raised a total of $97m in funding over 2 rounds.
Key Insights:
- Aimmune Therapeutics Series B Mar 12, 2015: $80m
- Aimmune Therapeutics Series A round: $17m
Industries
Aimmune Therapeutics is active in the following industries: